in our environmental health segment , our laboratory services business offers services designed to enable our customers to increase efficiencies and production time , while reducing maintenance costs , all of which continue to be critical for our customers . during fiscal year 2014 , we continued to experience growth in our laboratory services business , which included the addition of new customers to our onesource multivendor service offering . these increases were partially offset by decreased demand across some of our products in the environmental and industrial markets , primarily in the asian industrial end markets . we anticipate that the continued development of contaminant regulations and corresponding testing protocols will result in increased demand for efficient , analytically sensitive and information rich testing solutions . our consolidated gross margins decrease d 34 basis points in fiscal year 2014 , as compared to fiscal year 2013 , due to unfavorable changes in product mix , with an increase in sales of lower gross margin product offerings , pricing pressure , a higher mark-to-market loss for our postretirement benefit plans in fiscal year 2014 as compared to fiscal year 2013 , and negative impacts from foreign currency exchange rates . these items were partially offset by increased sales volume and cost containment and productivity initiatives . our consolidated operating margin decrease d 114 basis points in fiscal year 2014 , as compared to fiscal year 2013 , primarily due to a pre-tax loss of $ 75.9 million in fiscal year 2014 as compared to pre-tax income of $ 17.6 million in fiscal year 2013 for the mark-to-market adjustments for our postretirement plans and lower gross margins . these items were partially offset by increased sales volume , cost containment and productivity initiatives and lower restructuring charges . 29 we believe we are well positioned to continue to take advantage of the spending trends in our end markets and to promote our efficiencies in markets where current conditions may increase demand for certain services . overall , we believe that our strategic focus on human health and environmental health coupled with our breadth of end markets , deep portfolio of technologies and applications , leading market positions , global scale and financial strength will provide us with a foundation for growth . consolidated results of continuing operations revenue 2014 compared to 2013 . revenue for fiscal year 2014 was $ 2,237.2 million , as compared to $ 2,157.6 million for fiscal year 2013 , an increase of $ 79.6 million , or 4 % , which includes an approximate 1 % increase in revenue attributable to acquisitions and an approximate 1 % decrease in revenue attributable to changes in foreign exchange rates . the analysis in the remainder of this paragraph compares segment revenue for fiscal year 2014 as compared to fiscal year 2013 and includes the effect of foreign exchange rate fluctuations and acquisitions . the total increase in revenue reflects a $ 42.3 million , or 4 % , increase in our human health segment revenue , due to an increase in diagnostics market revenue of $ 39.8 million and an increase in research market revenue of $ 2.5 million . our environmental health segment revenue increase d $ 37.3 million , or 4 % , due to an increase in laboratory services market revenue of $ 33.8 million and an increase in environmental and industrial markets revenue of $ 3.5 million . as a result of adjustments to deferred revenue related to certain acquisitions required by business combination rules , we did not recognize $ 2.9 million of revenue primarily related to our informatics business in our human health segment for fiscal year 2014 and $ 7.3 million for fiscal year 2013 that otherwise would have been recorded by the acquired businesses during each of the respective periods . 2013 compared to 2012 . revenue for fiscal year 2013 was $ 2,157.6 million , as compared to $ 2,105.2 million for fiscal year 2012 , an increase of $ 52.4 million , or 2 % , which includes an approximate 1 % increase in revenue attributable to acquisitions and an approximate 0.4 % decrease in revenue attributable to changes in foreign exchange rates . the analysis in the remainder of this paragraph compares segment revenue for fiscal year 2013 as compared to fiscal year 2012 and includes the effect of foreign exchange rate fluctuations and acquisitions . the total increase in revenue reflects a $ 36.5 million , or 3 % , increase in our human health segment revenue , due to an increase in diagnostics market revenue of $ 22.8 million and an increase in research market revenue of $ 13.7 million . our environmental health segment revenue for fiscal year 2013 as compared to fiscal year 2012 increase d $ 15.9 million , or 2 % , due to an increase in laboratory services market revenue of $ 23.2 million , partially offset by decrease s in environmental and industrial markets revenue of $ 7.3 million . as a result of adjustments to deferred revenue related to certain acquisitions required by business combination rules , we did not recognize $ 7.3 million of revenue primarily related to our informatics business in our human health segment for fiscal year 2013 and $ 26.2 million for fiscal year 2012 that otherwise would have been recorded by the acquired businesses during each of the respective periods . cost of revenue 2014 compared to 2013 . cost of revenue for fiscal year 2014 was $ 1,232.6 million , as compared to $ 1,181.4 million for fiscal year 2013 , an increase of approximately $ 51.2 million , or 4 % . story_separator_special_tag accordingly , we undertook a review of certain of our trade names within our portfolio as part of a realignment of our marketing strategy , which resulted in pre-tax impairment charges of $ 73.4 million in our human health segment and $ 0.7 million in our environmental health segment during fiscal year 2012. interest and other expense , net interest and other expense , net , consisted of the following : replace_table_token_12_th 2014 compared to 2013 . interest and other expense , net , for fiscal year 2014 was an expense of $ 41.1 million , as compared to an expense of $ 64.1 million for fiscal year 2013 , a decrease of $ 23.0 million . the decrease in interest and other expense , net , in fiscal year 2014 as compared to fiscal year 2013 was primarily due to a decrease in interest expense and other expense . interest expense decrease d by $ 13.7 million in fiscal year 2014 as compared to fiscal year 2013 , primarily due to the redemption of our fixed rate 2015 notes in fiscal year 2013 , resulting in lower debt outstanding and an increased mix of variable rate debt with lower interest rates during fiscal year 2014. in addition , during fiscal year 2013 , we wrote-off $ 2.8 million for the remaining unamortized derivative losses for previously settled cash flow hedges and wrote-off $ 0.2 million for the remaining deferred debt issuance costs related to the prepayment of our 2015 notes . other expenses for fiscal year 2014 decrease d by $ 9.3 million as compared to fiscal year 2013 , primarily due to a prepayment premium of $ 11.1 million for the redemption of our 2015 notes in fiscal year 2013 , which was partially offset by expenses related to foreign currency transactions and translation of non-functional currency assets and liabilities . a more complete discussion of our liquidity is set forth below under the heading “ liquidity and capital resources . ” 2013 compared to 2012 . interest and other expense , net , for fiscal year 2013 was an expense of $ 64.1 million , as compared to an expense of $ 48.0 million for fiscal year 2012 , an increase of $ 16.2 million . the increase in interest and other expense , net , in fiscal year 2013 as compared to fiscal year 2012 was primarily due to an increase in other expense , net , resulting from a prepayment premium of $ 11.1 million for the redemption of our 2015 notes . interest expense increase d by $ 4.1 million in fiscal year 2013 as compared to fiscal year 2012 , primarily due to the write-off of $ 2.8 million for the remaining unamortized derivative losses for previously settled cash flow hedges and the write-off of $ 0.2 million for the remaining deferred debt issuance costs related to the prepayment of our 2015 notes . interest income decrease d by $ 0.1 million in fiscal year 2013 as compared to fiscal year 2012 , primarily due to lower cash balances throughout fiscal year 2013. other expenses for fiscal year 2013 increase d by $ 11.9 million as compared to fiscal year 2012 , and consisted primarily of the prepayment premium of $ 11.1 million for the redemption of our 2015 notes , expenses related to foreign currency transactions and translation of non-functional currency assets and liabilities . provision for ( benefit from ) income taxes 2014 compared to 2013 . the fiscal year 2014 provision for income taxes on continuing operations was $ 8.4 million , as compared to a benefit of $ 10.6 million for fiscal year 2013 . the effective tax rate on continuing operations was a provision of 5.0 % for fiscal year 2014 as compared to a benefit of 6.5 % for fiscal year 2013 . the provision for income taxes in fiscal year 2014 was primarily due to income in lower tax rate jurisdictions , partially offset by losses in higher rate jurisdictions and a tax benefit of $ 7.0 million related to discrete items . the benefit from income taxes in fiscal year 2013 was primarily due a tax benefit of $ 24.0 million related to discrete items and losses in higher tax rate jurisdictions , partially offset by a provision from income taxes related to profits in lower tax rate jurisdictions . the $ 24.0 million of discrete items includes $ 9.4 million for 35 lapses in statutes of limitations during the first quarter of fiscal year 2013 and $ 9.2 million primarily for lapses in statutes of limitations and audit settlements in the fourth quarter of fiscal year 2013 . 2013 compared to 2012 . the fiscal year 2013 benefit from income taxes on continuing operations was $ 10.6 million , as compared to a benefit of $ 16.1 million for fiscal year 2012 . the effective tax rate on continuing operations was a benefit of 6.5 % for fiscal year 2013 as compared to a benefit of 29.2 % for fiscal year 2012 . the benefit from income taxes in fiscal year 2013 was primarily due to a tax benefit of $ 24.0 million related to discrete items and losses in higher tax rate jurisdictions , partially offset by a provision from income taxes related to profits in lower tax rate jurisdictions . the $ 24.0 million of discrete items includes $ 9.4 million for lapses in statutes of limitations during the first quarter of fiscal year 2013 and $ 9.2 million primarily for lapses in statutes of limitations and audit settlements in the fourth quarter of fiscal year 2013. the benefit from income taxes in fiscal year 2012 was primarily due to a tax benefit of $ 7.0 million related to discrete items and losses in higher tax rate jurisdictions , which included the pre-tax impairment charges of $ 74.2 million , partially offset by a provision from income taxes related to profits in

net cash provided by continuing operations was $ 157.2 million for fiscal year 2013 , as compared to net cash provided by continuing operations of $ 154.0 million for fiscal year 2012 , an increase of $ 3.3 million . the cash provided by operating activities for fiscal year 2013 was principally a result of income from continuing operations of $ 174.3 million , and non-cash charges , including depreciation and amortization of $ 126.9 million , restructuring and contract termination charges , net , of $ 33.9 million , stock based compensation expense of $ 14.1 million and an asset impairment charge 42 of $ 0.2 million . these amounts were partially offset by a net decrease of $ 144.5 million in accrued expenses , other assets and liabilities and other items , a net increase in working capital of $ 29.3 million and income related to our postretirement benefit plans , including the mark-to-market adjustment in the fourth quarter of fiscal year 2013 , of $ 18.2 million . contributing to the net increase in working capital for fiscal year 2013 , excluding the effect of foreign exchange rate fluctuations , was an increase in accounts receivable of $ 14.1 million , an increase in inventory of $ 14.2 million , and a decrease in accounts payable of $ 1.1 million . the increase in accounts receivable was a result of higher sales volume late in the fourth quarter of fiscal year 2013 . the increase in inventory was primarily a result of realigning operations , research and development resources and production resources within our environmental health and human health segments to ensure responsiveness to customer requirements as this realignment occurs . the decrease in accounts payable was primarily a result of the timing of disbursements during the fourth quarter of fiscal year 2013 .


 Write a concise suspicious activity report of the following text delimited by triple backquotes. Return your response as a formal report which covers the key points highlighting the location,dates,entity names and account holder information in chronological order of the text.
     ```net cash provided by continuing operations was $ 157.2 million for fiscal year 2013 , as compared to net cash provided by continuing operations of $ 154.0 million for fiscal year 2012 , an increase of $ 3.3 million . the cash provided by operating activities for fiscal year 2013 was principally a result of income from continuing operations of $ 174.3 million , and non-cash charges , including depreciation and amortization of $ 126.9 million , restructuring and contract termination charges , net , of $ 33.9 million , stock based compensation expense of $ 14.1 million and an asset impairment charge 42 of $ 0.2 million . these amounts were partially offset by a net decrease of $ 144.5 million in accrued expenses , other assets and liabilities and other items , a net increase in working capital of $ 29.3 million and income related to our postretirement benefit plans , including the mark-to-market adjustment in the fourth quarter of fiscal year 2013 , of $ 18.2 million . contributing to the net increase in working capital for fiscal year 2013 , excluding the effect of foreign exchange rate fluctuations , was an increase in accounts receivable of $ 14.1 million , an increase in inventory of $ 14.2 million , and a decrease in accounts payable of $ 1.1 million . the increase in accounts receivable was a result of higher sales volume late in the fourth quarter of fiscal year 2013 . the increase in inventory was primarily a result of realigning operations , research and development resources and production resources within our environmental health and human health segments to ensure responsiveness to customer requirements as this realignment occurs . the decrease in accounts payable was primarily a result of the timing of disbursements during the fourth quarter of fiscal year 2013 .
```    
 Suspicious Activity Report : in our environmental health segment , our laboratory services business offers services designed to enable our customers to increase efficiencies and production time , while reducing maintenance costs , all of which continue to be critical for our customers . during fiscal year 2014 , we continued to experience growth in our laboratory services business , which included the addition of new customers to our onesource multivendor service offering . these increases were partially offset by decreased demand across some of our products in the environmental and industrial markets , primarily in the asian industrial end markets . we anticipate that the continued development of contaminant regulations and corresponding testing protocols will result in increased demand for efficient , analytically sensitive and information rich testing solutions . our consolidated gross margins decrease d 34 basis points in fiscal year 2014 , as compared to fiscal year 2013 , due to unfavorable changes in product mix , with an increase in sales of lower gross margin product offerings , pricing pressure , a higher mark-to-market loss for our postretirement benefit plans in fiscal year 2014 as compared to fiscal year 2013 , and negative impacts from foreign currency exchange rates . these items were partially offset by increased sales volume and cost containment and productivity initiatives . our consolidated operating margin decrease d 114 basis points in fiscal year 2014 , as compared to fiscal year 2013 , primarily due to a pre-tax loss of $ 75.9 million in fiscal year 2014 as compared to pre-tax income of $ 17.6 million in fiscal year 2013 for the mark-to-market adjustments for our postretirement plans and lower gross margins . these items were partially offset by increased sales volume , cost containment and productivity initiatives and lower restructuring charges . 29 we believe we are well positioned to continue to take advantage of the spending trends in our end markets and to promote our efficiencies in markets where current conditions may increase demand for certain services . overall , we believe that our strategic focus on human health and environmental health coupled with our breadth of end markets , deep portfolio of technologies and applications , leading market positions , global scale and financial strength will provide us with a foundation for growth . consolidated results of continuing operations revenue 2014 compared to 2013 . revenue for fiscal year 2014 was $ 2,237.2 million , as compared to $ 2,157.6 million for fiscal year 2013 , an increase of $ 79.6 million , or 4 % , which includes an approximate 1 % increase in revenue attributable to acquisitions and an approximate 1 % decrease in revenue attributable to changes in foreign exchange rates . the analysis in the remainder of this paragraph compares segment revenue for fiscal year 2014 as compared to fiscal year 2013 and includes the effect of foreign exchange rate fluctuations and acquisitions . the total increase in revenue reflects a $ 42.3 million , or 4 % , increase in our human health segment revenue , due to an increase in diagnostics market revenue of $ 39.8 million and an increase in research market revenue of $ 2.5 million . our environmental health segment revenue increase d $ 37.3 million , or 4 % , due to an increase in laboratory services market revenue of $ 33.8 million and an increase in environmental and industrial markets revenue of $ 3.5 million . as a result of adjustments to deferred revenue related to certain acquisitions required by business combination rules , we did not recognize $ 2.9 million of revenue primarily related to our informatics business in our human health segment for fiscal year 2014 and $ 7.3 million for fiscal year 2013 that otherwise would have been recorded by the acquired businesses during each of the respective periods . 2013 compared to 2012 . revenue for fiscal year 2013 was $ 2,157.6 million , as compared to $ 2,105.2 million for fiscal year 2012 , an increase of $ 52.4 million , or 2 % , which includes an approximate 1 % increase in revenue attributable to acquisitions and an approximate 0.4 % decrease in revenue attributable to changes in foreign exchange rates . the analysis in the remainder of this paragraph compares segment revenue for fiscal year 2013 as compared to fiscal year 2012 and includes the effect of foreign exchange rate fluctuations and acquisitions . the total increase in revenue reflects a $ 36.5 million , or 3 % , increase in our human health segment revenue , due to an increase in diagnostics market revenue of $ 22.8 million and an increase in research market revenue of $ 13.7 million . our environmental health segment revenue for fiscal year 2013 as compared to fiscal year 2012 increase d $ 15.9 million , or 2 % , due to an increase in laboratory services market revenue of $ 23.2 million , partially offset by decrease s in environmental and industrial markets revenue of $ 7.3 million . as a result of adjustments to deferred revenue related to certain acquisitions required by business combination rules , we did not recognize $ 7.3 million of revenue primarily related to our informatics business in our human health segment for fiscal year 2013 and $ 26.2 million for fiscal year 2012 that otherwise would have been recorded by the acquired businesses during each of the respective periods . cost of revenue 2014 compared to 2013 . cost of revenue for fiscal year 2014 was $ 1,232.6 million , as compared to $ 1,181.4 million for fiscal year 2013 , an increase of approximately $ 51.2 million , or 4 % . story_separator_special_tag accordingly , we undertook a review of certain of our trade names within our portfolio as part of a realignment of our marketing strategy , which resulted in pre-tax impairment charges of $ 73.4 million in our human health segment and $ 0.7 million in our environmental health segment during fiscal year 2012. interest and other expense , net interest and other expense , net , consisted of the following : replace_table_token_12_th 2014 compared to 2013 . interest and other expense , net , for fiscal year 2014 was an expense of $ 41.1 million , as compared to an expense of $ 64.1 million for fiscal year 2013 , a decrease of $ 23.0 million . the decrease in interest and other expense , net , in fiscal year 2014 as compared to fiscal year 2013 was primarily due to a decrease in interest expense and other expense . interest expense decrease d by $ 13.7 million in fiscal year 2014 as compared to fiscal year 2013 , primarily due to the redemption of our fixed rate 2015 notes in fiscal year 2013 , resulting in lower debt outstanding and an increased mix of variable rate debt with lower interest rates during fiscal year 2014. in addition , during fiscal year 2013 , we wrote-off $ 2.8 million for the remaining unamortized derivative losses for previously settled cash flow hedges and wrote-off $ 0.2 million for the remaining deferred debt issuance costs related to the prepayment of our 2015 notes . other expenses for fiscal year 2014 decrease d by $ 9.3 million as compared to fiscal year 2013 , primarily due to a prepayment premium of $ 11.1 million for the redemption of our 2015 notes in fiscal year 2013 , which was partially offset by expenses related to foreign currency transactions and translation of non-functional currency assets and liabilities . a more complete discussion of our liquidity is set forth below under the heading “ liquidity and capital resources . ” 2013 compared to 2012 . interest and other expense , net , for fiscal year 2013 was an expense of $ 64.1 million , as compared to an expense of $ 48.0 million for fiscal year 2012 , an increase of $ 16.2 million . the increase in interest and other expense , net , in fiscal year 2013 as compared to fiscal year 2012 was primarily due to an increase in other expense , net , resulting from a prepayment premium of $ 11.1 million for the redemption of our 2015 notes . interest expense increase d by $ 4.1 million in fiscal year 2013 as compared to fiscal year 2012 , primarily due to the write-off of $ 2.8 million for the remaining unamortized derivative losses for previously settled cash flow hedges and the write-off of $ 0.2 million for the remaining deferred debt issuance costs related to the prepayment of our 2015 notes . interest income decrease d by $ 0.1 million in fiscal year 2013 as compared to fiscal year 2012 , primarily due to lower cash balances throughout fiscal year 2013. other expenses for fiscal year 2013 increase d by $ 11.9 million as compared to fiscal year 2012 , and consisted primarily of the prepayment premium of $ 11.1 million for the redemption of our 2015 notes , expenses related to foreign currency transactions and translation of non-functional currency assets and liabilities . provision for ( benefit from ) income taxes 2014 compared to 2013 . the fiscal year 2014 provision for income taxes on continuing operations was $ 8.4 million , as compared to a benefit of $ 10.6 million for fiscal year 2013 . the effective tax rate on continuing operations was a provision of 5.0 % for fiscal year 2014 as compared to a benefit of 6.5 % for fiscal year 2013 . the provision for income taxes in fiscal year 2014 was primarily due to income in lower tax rate jurisdictions , partially offset by losses in higher rate jurisdictions and a tax benefit of $ 7.0 million related to discrete items . the benefit from income taxes in fiscal year 2013 was primarily due a tax benefit of $ 24.0 million related to discrete items and losses in higher tax rate jurisdictions , partially offset by a provision from income taxes related to profits in lower tax rate jurisdictions . the $ 24.0 million of discrete items includes $ 9.4 million for 35 lapses in statutes of limitations during the first quarter of fiscal year 2013 and $ 9.2 million primarily for lapses in statutes of limitations and audit settlements in the fourth quarter of fiscal year 2013 . 2013 compared to 2012 . the fiscal year 2013 benefit from income taxes on continuing operations was $ 10.6 million , as compared to a benefit of $ 16.1 million for fiscal year 2012 . the effective tax rate on continuing operations was a benefit of 6.5 % for fiscal year 2013 as compared to a benefit of 29.2 % for fiscal year 2012 . the benefit from income taxes in fiscal year 2013 was primarily due to a tax benefit of $ 24.0 million related to discrete items and losses in higher tax rate jurisdictions , partially offset by a provision from income taxes related to profits in lower tax rate jurisdictions . the $ 24.0 million of discrete items includes $ 9.4 million for lapses in statutes of limitations during the first quarter of fiscal year 2013 and $ 9.2 million primarily for lapses in statutes of limitations and audit settlements in the fourth quarter of fiscal year 2013. the benefit from income taxes in fiscal year 2012 was primarily due to a tax benefit of $ 7.0 million related to discrete items and losses in higher tax rate jurisdictions , which included the pre-tax impairment charges of $ 74.2 million , partially offset by a provision from income taxes related to profits in

